103 related articles for article (PubMed ID: 6231788)
21. Effect of cyclosporin A on low-dose streptozotocin diabetes in mice.
Kolb H; Oschilewski M; Schwab E; Oschilewski U; Kiesel U
Diabetes Res; 1985 Jul; 2(4):191-3. PubMed ID: 3910327
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice.
Kim JH; Stewart TP; Soltani-Bejnood M; Wang L; Fortuna JM; Mostafa OA; Moustaid-Moussa N; Shoieb AM; McEntee MF; Wang Y; Bechtel L; Naggert JK
J Endocrinol; 2006 Nov; 191(2):437-46. PubMed ID: 17088413
[TBL] [Abstract][Full Text] [Related]
23. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice.
Tomaru M; Takano H; Osakabe N; Yasuda A; Inoue K; Yanagisawa R; Ohwatari T; Uematsu H
Nutrition; 2007 Apr; 23(4):351-5. PubMed ID: 17350804
[TBL] [Abstract][Full Text] [Related]
24. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
[TBL] [Abstract][Full Text] [Related]
25. CMV-hFasL transgenic mice are sensitive to low doses of streptozotocin-induced type I diabetes mellitus.
Lin B; Zhang ZL; Yu LY; Guo LH
Acta Pharmacol Sin; 2003 Dec; 24(12):1199-204. PubMed ID: 14653944
[TBL] [Abstract][Full Text] [Related]
26. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
27. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
Sternesjö J; Welsh N; Sandler S
Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
[TBL] [Abstract][Full Text] [Related]
28. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice.
Szebeni A; Prohászka Z; Buzás E; Falus A; Kecskeméti V
Inflamm Res; 2008 Apr; 57(4):178-82. PubMed ID: 18351435
[TBL] [Abstract][Full Text] [Related]
29. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
30. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.
Wen Y; Ouyang J; Yang R; Chen J; Liu Y; Zhou X; Burt RK
Biochem Biophys Res Commun; 2008 Sep; 374(2):282-7. PubMed ID: 18625200
[TBL] [Abstract][Full Text] [Related]
31. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
[TBL] [Abstract][Full Text] [Related]
32. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
Croze F; Prud'homme GJ
J Gene Med; 2003 May; 5(5):425-37. PubMed ID: 12731091
[TBL] [Abstract][Full Text] [Related]
34. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
[TBL] [Abstract][Full Text] [Related]
35. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.
Herold KC; Vezys V; Sun Q; Viktora D; Seung E; Reiner S; Brown DR
J Immunol; 1996 May; 156(9):3521-7. PubMed ID: 8617981
[TBL] [Abstract][Full Text] [Related]
36. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.
Rossini AA; Appel MC; Williams RM; Like AA
Diabetes; 1977 Oct; 26(10):916-20. PubMed ID: 143386
[TBL] [Abstract][Full Text] [Related]
37. Analysis of 22 immunomodulatory substances for efficacy in low-dose streptozotocin-induced diabetes.
Kolb H; Oschilewski M; Oschilewski U; Schwab E; Moumé CM; Greulich B; Burkart V; Zielasek J; Kiesel U
Diabetes Res; 1987 Sep; 6(1):21-7. PubMed ID: 3319352
[TBL] [Abstract][Full Text] [Related]
38. [Experimental diabetes in mice infected with Coxsackie viruses].
Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
Biull Eksp Biol Med; 1987 Feb; 103(2):163-6. PubMed ID: 3028528
[TBL] [Abstract][Full Text] [Related]
39. Melphalan attenuates streptozotocin-induced diabetes in C57BL/6 and C3H3 mice.
Biener J; Flechner I; Laron Z
Isr J Med Sci; 1988 Mar; 24(3):190-1. PubMed ID: 2967265
[No Abstract] [Full Text] [Related]
40. Ammonium chloride potentiation of streptozotocin-induced diabetes in juvenile pigs.
Korompai FL; Ustinova E; Taulman AC; Yuan SY
Horm Metab Res; 2000 Jul; 32(7):256-8. PubMed ID: 10965929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
